Black Friday saleUp to 70% OFF

ESRX

ESRX WEEKLY CHART Express Scripts Holding Co ENTRY LEVELESRX is currently on a downtrend, with MA100 over MA50 over MA20. However, market successfully rejected 0.5 retracement from post-2008 low / 2015 high, also triggering a bullish divergence. Market may bounce or range from now on. A falling wedge could end this downtrend. Open long orders with price over MA50 or MA20 over MA50 in the $65-$70 zone (which is 2.3X book value), stop-loss under 56. 1st target at wedge pattern, 2nd target at ATH. This is a 777-day trade, with annualized return of 17% (excluding share earnings) WNZ Get live updates and analysis of the cryptocurrency market: t.me
ELong
by WaineNZeddmo
Watch ('value' buy) / potential swing positionI've owned ESRX in the past and have enjoyed significant growth. It is now priced (based on evaluation) where I would be interested in buying again. It is a good company, financial strong, and has a strong track record. Technically, recently bearish, but still overall trending up (L.T.). Broke 68.06 support. If 65.55 is tested and holds along w/ bullish price action, I would considering buying with estimated target close to $95 - $100. If 65.55 breaks, I would look for potential buying opportunity around $60. Bottom line: $67 is a good price. With a little momentum to the up side and this could be a good swing position to own. 1D: 1M:
E
by JLJ002500
THIS WEEK'S EARNINGS PLAYS VIA OPTIONS -- PCLN, ESRX, DEI ground through a large number of next week's earnings announcements, thinking I might find a nugget or two to play via options, but was somewhat disappointed. I've never played ESRX before, which announces on Tuesday after market close, probably because I'm not a fan of anything remotely pharmaceutical for these plays beyond the "uber" names like LLY and AMGN. Price gyrations can be wilder than the garden variety earnings announcement and ESRX has been subject to being "Hillaried," a phenom which can occur at any time ... . Naturally, there's PCLN, which announces earnings on Wednesday, but the liquidity in the options is horrible, with wide bid/ask spreads which increases the likelihood that you won't get a fill on any setup at a fair price -- at least at the mid. Given the quality of the liquidity, however, it might be worth attempting a fill of a setup a good ways above the mid price and see if it goes ... . If it doesn't fill, pass on a play; it just isn't worth chasing price on an underlying with options as crappy as PCLN's. DE, which announces on Friday before market open. My guess is that the company's performance -- like other machinery companies with heavy export reliance (e.g., CAT) -- will continue to flag on Greenback strength, so I may look to skew any setup a tad bearish, particularly since the bounce off of 1/20 low of 70.16 (even though I usually assume a directionally neutral stance on these plays, since it's impossible to gauge market reaction to any particular announcement). Naturally, there are other earnings announcements that could be played in some other fashion (e.g., trading the underlying directly), but these are the only ones having the hallmarks of good premium selling plays: (1) high implied volatility rank; (2) high implied volatility; (3) option liquidity (with the exception of PCLN); and (4) the availability of weeklies.
NYSE:DE
by NaughtyPines
2